Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior

Amanda Eskelund, Yan Li, David P. Budac, Heidi K. Müller, Maria E. Gulinello, Connie Sanchez, Gregers Wegener

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The metabolism of tryptophan through kynurenine and serotonin pathways is linked to depression. Here, effects of different drugs with antidepressant properties (vortioxetine, fluoxetine, and ketamine) on various tryptophan metabolites in different brain regions and plasma were examined using tandem mass spectrometry (LC-MS/MS), in Flinders Sensitive Line rats, a genetic rat model of depression, and its controls: Flinders Sensitive Line and Sprague-Dawley rats. Protein levels of kynurenine pathway enzymes were measured in the brains and livers of these rat strains. Furthermore, effects of vortioxetine on tryptophan metabolites were assessed in the cortical regions of lupus mice (MRL/MpJ-FasIpr), a murine model of increased depression-like behavior associated with inflammation. Sustained vortioxetine or fluoxetine (at doses aimed to fully occupy serotonin transporter via food or drinking water for at least 14 days) reduced levels of the excitotoxin quinolinic acid (QUIN) in various brain regions in all rats. Furthermore, chronic vortioxetine reduced levels of QUIN in MRL/MpJ-FasIpr mice. Acute i.p. administration of fluoxetine (10 mg/kg) or vortioxetine (10 mg/kg) led to reduced brain 5-hydroxyindoleacetic acid in Sprague-Dawley rats (2, 4, 6, and 8 h) and a similar trend was evident in Flinders Sensitive Line and Flinders Sensitive Line rats after 4 h. In contrast, single or repeated administration of ketamine (15 mg/kg i.p.) did not induce significant changes in metabolite levels. In conclusion, sustained vortioxetine and fluoxetine administration decreased QUIN independent of species, while ketamine was ineffective. These results support the hypothesis that modulating tryptophan metabolism may be part of the mechanism of action for some antidepressants.

Original languageEnglish (US)
JournalJournal of Neurochemistry
DOIs
StateAccepted/In press - 2017

Fingerprint

Metabolites
Tryptophan
Antidepressive Agents
Rats
Rodentia
Fluoxetine
Depression
Quinolinic Acid
Ketamine
Brain
Pharmaceutical Preparations
Kynurenine
Sprague Dawley Rats
Metabolism
Serotonin Plasma Membrane Transport Proteins
Hydroxyindoleacetic Acid
Genetic Models
Neurotoxins
Tandem Mass Spectrometry
Drinking Water

Keywords

  • SSRI
  • Depression
  • Kynurenine
  • Quinolinic acid
  • Tryptophan
  • Vortioxetine

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior. / Eskelund, Amanda; Li, Yan; Budac, David P.; Müller, Heidi K.; Gulinello, Maria E.; Sanchez, Connie; Wegener, Gregers.

In: Journal of Neurochemistry, 2017.

Research output: Contribution to journalArticle

Eskelund, Amanda ; Li, Yan ; Budac, David P. ; Müller, Heidi K. ; Gulinello, Maria E. ; Sanchez, Connie ; Wegener, Gregers. / Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior. In: Journal of Neurochemistry. 2017.
@article{3fd9be8d7e9d47b18db76e82a205c390,
title = "Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior",
abstract = "The metabolism of tryptophan through kynurenine and serotonin pathways is linked to depression. Here, effects of different drugs with antidepressant properties (vortioxetine, fluoxetine, and ketamine) on various tryptophan metabolites in different brain regions and plasma were examined using tandem mass spectrometry (LC-MS/MS), in Flinders Sensitive Line rats, a genetic rat model of depression, and its controls: Flinders Sensitive Line and Sprague-Dawley rats. Protein levels of kynurenine pathway enzymes were measured in the brains and livers of these rat strains. Furthermore, effects of vortioxetine on tryptophan metabolites were assessed in the cortical regions of lupus mice (MRL/MpJ-FasIpr), a murine model of increased depression-like behavior associated with inflammation. Sustained vortioxetine or fluoxetine (at doses aimed to fully occupy serotonin transporter via food or drinking water for at least 14 days) reduced levels of the excitotoxin quinolinic acid (QUIN) in various brain regions in all rats. Furthermore, chronic vortioxetine reduced levels of QUIN in MRL/MpJ-FasIpr mice. Acute i.p. administration of fluoxetine (10 mg/kg) or vortioxetine (10 mg/kg) led to reduced brain 5-hydroxyindoleacetic acid in Sprague-Dawley rats (2, 4, 6, and 8 h) and a similar trend was evident in Flinders Sensitive Line and Flinders Sensitive Line rats after 4 h. In contrast, single or repeated administration of ketamine (15 mg/kg i.p.) did not induce significant changes in metabolite levels. In conclusion, sustained vortioxetine and fluoxetine administration decreased QUIN independent of species, while ketamine was ineffective. These results support the hypothesis that modulating tryptophan metabolism may be part of the mechanism of action for some antidepressants.",
keywords = "SSRI, Depression, Kynurenine, Quinolinic acid, Tryptophan, Vortioxetine",
author = "Amanda Eskelund and Yan Li and Budac, {David P.} and M{\"u}ller, {Heidi K.} and Gulinello, {Maria E.} and Connie Sanchez and Gregers Wegener",
year = "2017",
doi = "10.1111/jnc.14043",
language = "English (US)",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior

AU - Eskelund, Amanda

AU - Li, Yan

AU - Budac, David P.

AU - Müller, Heidi K.

AU - Gulinello, Maria E.

AU - Sanchez, Connie

AU - Wegener, Gregers

PY - 2017

Y1 - 2017

N2 - The metabolism of tryptophan through kynurenine and serotonin pathways is linked to depression. Here, effects of different drugs with antidepressant properties (vortioxetine, fluoxetine, and ketamine) on various tryptophan metabolites in different brain regions and plasma were examined using tandem mass spectrometry (LC-MS/MS), in Flinders Sensitive Line rats, a genetic rat model of depression, and its controls: Flinders Sensitive Line and Sprague-Dawley rats. Protein levels of kynurenine pathway enzymes were measured in the brains and livers of these rat strains. Furthermore, effects of vortioxetine on tryptophan metabolites were assessed in the cortical regions of lupus mice (MRL/MpJ-FasIpr), a murine model of increased depression-like behavior associated with inflammation. Sustained vortioxetine or fluoxetine (at doses aimed to fully occupy serotonin transporter via food or drinking water for at least 14 days) reduced levels of the excitotoxin quinolinic acid (QUIN) in various brain regions in all rats. Furthermore, chronic vortioxetine reduced levels of QUIN in MRL/MpJ-FasIpr mice. Acute i.p. administration of fluoxetine (10 mg/kg) or vortioxetine (10 mg/kg) led to reduced brain 5-hydroxyindoleacetic acid in Sprague-Dawley rats (2, 4, 6, and 8 h) and a similar trend was evident in Flinders Sensitive Line and Flinders Sensitive Line rats after 4 h. In contrast, single or repeated administration of ketamine (15 mg/kg i.p.) did not induce significant changes in metabolite levels. In conclusion, sustained vortioxetine and fluoxetine administration decreased QUIN independent of species, while ketamine was ineffective. These results support the hypothesis that modulating tryptophan metabolism may be part of the mechanism of action for some antidepressants.

AB - The metabolism of tryptophan through kynurenine and serotonin pathways is linked to depression. Here, effects of different drugs with antidepressant properties (vortioxetine, fluoxetine, and ketamine) on various tryptophan metabolites in different brain regions and plasma were examined using tandem mass spectrometry (LC-MS/MS), in Flinders Sensitive Line rats, a genetic rat model of depression, and its controls: Flinders Sensitive Line and Sprague-Dawley rats. Protein levels of kynurenine pathway enzymes were measured in the brains and livers of these rat strains. Furthermore, effects of vortioxetine on tryptophan metabolites were assessed in the cortical regions of lupus mice (MRL/MpJ-FasIpr), a murine model of increased depression-like behavior associated with inflammation. Sustained vortioxetine or fluoxetine (at doses aimed to fully occupy serotonin transporter via food or drinking water for at least 14 days) reduced levels of the excitotoxin quinolinic acid (QUIN) in various brain regions in all rats. Furthermore, chronic vortioxetine reduced levels of QUIN in MRL/MpJ-FasIpr mice. Acute i.p. administration of fluoxetine (10 mg/kg) or vortioxetine (10 mg/kg) led to reduced brain 5-hydroxyindoleacetic acid in Sprague-Dawley rats (2, 4, 6, and 8 h) and a similar trend was evident in Flinders Sensitive Line and Flinders Sensitive Line rats after 4 h. In contrast, single or repeated administration of ketamine (15 mg/kg i.p.) did not induce significant changes in metabolite levels. In conclusion, sustained vortioxetine and fluoxetine administration decreased QUIN independent of species, while ketamine was ineffective. These results support the hypothesis that modulating tryptophan metabolism may be part of the mechanism of action for some antidepressants.

KW - SSRI

KW - Depression

KW - Kynurenine

KW - Quinolinic acid

KW - Tryptophan

KW - Vortioxetine

UR - http://www.scopus.com/inward/record.url?scp=85019555432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019555432&partnerID=8YFLogxK

U2 - 10.1111/jnc.14043

DO - 10.1111/jnc.14043

M3 - Article

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

ER -